Cellebrite DI Ltd.

NASDAQ: CLBT · Real-Time Price · USD
15.33
1.34 (9.58%)
At close: Aug 14, 2025, 3:59 PM
15.43
0.65%
Pre-market: Aug 15, 2025, 04:19 AM EDT

Cellebrite DI Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
401.2M 325.11M 270.65M 246.25M
Cost of Revenue
62.59M 53.23M 50.75M 42.56M
Gross Profit
338.61M 271.88M 219.91M 203.69M
Operating Income
56.91M 33.24M 1.04M 13.82M
Interest Income
18.22M 8.89M 1.6M 68.48M
Pretax Income
-275.98M -75.56M 120.76M 82.31M
Net Income
-283.01M -81.1M 120.81M 71.4M
Selling & General & Admin
183.29M 154.26M 138.24M 124.33M
Research & Development
98.42M 84.39M 80.62M 65.54M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
281.7M 238.64M 218.86M 189.87M
Interest Expense
349.76M 141K 119.72M 564K
Selling & Marketing Expenses
132.39M 110.81M 97.39M 76.39M
Cost & Expenses
344.3M 291.87M 269.61M 232.42M
Income Tax Expense
7.02M 5.54M -45K 10.91M
Shares Outstanding (Basic)
209.47M 190.15M 182.69M 144M
Shares Outstanding (Diluted)
209.47M 190.15M 195.39M 161.54M
EPS (Basic)
-1.35 -0.43 0.64 0.50
EPS (Diluted)
-1.35 -0.43 0.59 0.44
EBITDA
67.51M -64.8M 10.24M 89.88M
EBIT
56.91M -74.81M 1.04M 13.82M
Depreciation & Amortization
10.61M 10.01M 9.19M 7.01M